Novel Digital Technologies and Biomarkers to Characterise Depression, Upcoming Webinar Hosted by Xtalks

In this free webinar, the featured speakers will discuss novel digital technologies for better symptom detection in the development of treatments for depression. Attendees will learn about technologies that are useful to distinguish between depressed and healthy subjects, and how accurate classifiers (depressed vs. healthy) can be built using parsimonious models with select digital biomarkers.

News provided by

Xtalks

Oct 12, 2021, 08:30 ET


TORONTO, Oct. 12, 2021 /PRNewswire-PRWeb/ -- The development of new treatment options for depression is hindered by a lack of objective, clinically relevant outcome measures that can adequately capture daily fluctuations in mood and cognition. Novel digital technologies offer the potential for more objective and precise symptom detection, but which best characterise depression?

In efforts to address this question, Novartis evaluated seven digital technologies spanning eye-tracking in the clinic to the daily use of a Cambridge Cognition mobile app at home. Recently published in Frontiers in Psychiatry, the researchers covered:

  • Which technologies are useful to distinguish between depressed and healthy subjects?
  • Can we build accurate classifiers (depressed vs. healthy) using parsimonious models with select digital biomarkers?
  • Can we explain between-subject variation in MADRS (and possibly predict individual MADRS scores) using digital biomarker data?

In this webinar, experts from Novartis and Cambridge Cognition will share lessons learned evaluating novel digital endpoints and building parsimonious models with high diagnostic accuracy and the potential to predict a standard clinical outcome for patients with depression.

Join Francesca Cormack, PhD, Director of Research & Innovation at Cambridge Cognition, along with experts from Novartis, Jelena Curcic, PhD, Senior Data Scientist and Kristin Hannesdottir, PhD, Translational Medicine and Clinical Endpoint Expert, for the live webinar on Thursday, October 28, 2021 at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Novel Digital Technologies and Biomarkers to Characterise Depression.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]

SOURCE Xtalks